natgillin/translations-raw huggingface dataset:
If you wish to get pregnant or if you already became pregnant while taking this medicine, talk to your doctor immediately as you should be switched to a safer alternative treatment (e.g. heparin) if you are planning a pregnancy or immediately after recognition of pregnancy.
Če želite med jemanjem tega zdravila zanositi ali ste že zanosili, se nemudoma pogovorite z zdravnikom, saj morate v primeru, da načrtujete nosečnost, ali takoj potem, ko ugotovite, da ste zanosili, preiti na varnejše drugo zdravljenje (npr. heparin).
If the patient becomes pregnant while taking <…>, the patient should immediately be switched to a safer alternative treatment (e.g. heparin) and close follow-up including level II ultrasound should be recommended.
Če bolnica med jemanjem zdravila <…> zanosi, mora nemudoma preiti na varnejše drugo zdravljenje (npr. heparin), pri čemer se priporoča skrbno spremljanje, vključno z ultrazvočno preiskavo II.
In nursing mothers, the active ingredient passes into the breast milk, though in such small amounts that no adverse reactions are likely to occur in the infant.
Učinkovina pri doječih materah prehaja v mleko, vendar v tako majhnih količinah, da se pri otroku verjetno ne bo pojavil noben neželeni učinek.
Frequency not known: pulmonary arterial hypertension (increased blood pressure in the arteries (blood vessels) of the lungs)
Neznana pogostnost: Pljučna arterijska hipertenzija (zvišan krvni tlak v pljučnih arterijah (krvnih žilah v pljučih))
Phenprocoumon - Risk of birth defects and foetal loss following first trimester exposure as a function of the time of withdrawal (EPITT no 18902)
Fenprokumon - tveganje za prirojene napake in splav po izpostavljenosti v prvem trimesečju v odvisnosti od časa odtegnitve (EPITT št. 18902)
Common: pneumonia (including bacterial, viral, and fungal), upper respiratory tract infection/inflammation, herpes virus infection (including cytomegalovirus-CMV), enterocolitis infection, sepsis (including uncommon cases with fatal outcomes)
Pogosti: pljučnica (vključno z bakterijsko, virusno in mikotično pljučnico), okužba/vnetje zgornjih dihal, okužba z virusi herpesa (vključno s citomegalovirusom - CMV), enterokolitis, sepsa (tudi občasni primeri s smrtnimi izidi)
Amitriptyline - Dry eye (EPITT no 19173)
Amitriptilin - suhe oči (EPITT št. 19173)
Undesirable effects Tabulated list of adverse reactions Skin and subcutaneous tissue disorders Frequency ‘not known': Angioedema, urticaria
Tabelarični povzetek neželenih učinkov Bolezni kože in podkožja Neznana pogostnost: Angioedem, urtikarija
As a precaution, however, prophylaxis involving the administration of vitamin K1 to the infant concerned is recommended.
Kot previdnostni ukrep se pri dojenčkih priporoča profilaksa z dajanjem vitamina K1.
If you are breastfeeding, <…> passes into the breast milk, though in such small amounts that no adverse reactions are likely to occur to your child.
Če dojite, zdravilo <…> prehaja v mleko, vendar v tako majhnih količinah, da se pri otroku verjetno ne bo pojavil noben neželeni učinek.
Frequency not known: pulmonary arterial hypertension
Neznana pogostnost: Pljučna arterijska hipertenzija Navodilo za uporabo
Possible side effects Frequency ‘not known': Dry eyes
Možni neželeni učinki Neznana pogostnost: Suhe oči
Common side effects (may affect up to 1 in 10 people) Infections: pneumonia, herpes virus infection (including cytomegalovirus-CMV), upper respiratory tract infection, serious infection of the blood or tissues (including uncommon cases with fatal outcomes)
Pogosti neželeni učinki (pojavijo se lahko pri največ 1 od 10 bolnikov) Okužbe: pljučnica, okužba z virusi herpesa (vključno s citomegalovirusom - CMV), okužba zgornjih dihal in resna okužba krvi ali tkiv (tudi občasni primeri s smrtnimi izidi)
In humans phenprocoumon crosses the placental barrier.
Fenprokumon pri ljudeh prehaja skozi posteljico.
Based on human experience phenprocoumon may cause birth defects and foetal death when administered during pregnancy.
Na podlagi izkušenj pri ljudeh lahko dajanje fenprokumona med nosečnostjo povzroči prirojene napake in smrt plodu.
You must prevent becoming pregnant by taking effective contraceptive measures during therapy with <…> and in the period of 3 months after completion of the treatment with <…> due to the increased risk of foetal malformations.
Med zdravljenjem z zdravilom <…> in tri mesece po končanem zdravljenju z zdravilom <…> morate zaradi povečanega tveganja za malformacije pri plodu uporabljati učinkovito kontracepcijo, da preprečite zanositev.
Not known: frequency cannot be estimated from available data
Neznana pogostnost: pogostnosti iz razpoložljivih podatkov ni mogoče oceniti otekanje obraza, ustnic, jezika ali žrela koprivnica
Summary of product characteristics 4.8.
4.8 Neželeni učinki
Vortioxetine - Angioedema and urticaria (EPITT no
Vortioksetin - angioedem in urtikarija (EPITT št. 19099)
Dasatinib - Cytomegalovirus (CMV) reactivation (EPITT no
Dasatinib - reaktivacija citomegalovirusa (CMV) (EPITT št. 19111)
What you need to know before you take <…>
Kaj morate vedeti, preden boste vzeli zdravilo <…> Nosečnost, dojenje in plodnost
Hives
ravni.
Undesirable effects Under SOC ‘Eye disorders' Frequency ‘not known': Dry eye
Pod organskim sistemom „Očesne bolezni“ Neznana pogostnost: Suhe oči Navodilo za uporabo 4.
These reactions resolve over an average of 4 days.
Tovrstne reakcije minejo povprečno v 4 dneh.
Reconstitute the vaccine as described above.
Rekonstituirajte cepivo, kot je opisano zgoraj.
The cough may last for one to two months or longer.
Kašelj lahko traja en do dva meseca ali dlje.
Each individual pack cannot be sold separately
Posameznega pakiranja ni možno prodajati ločeno.
Date of latest renewal: 31 August 2010
Datum zadnjega podaljšanja: 31. avgust 2010
This is a normal observation.
To opažanje je normalno.
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 23 October 2000
DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Datum prve odobritve: 23. oktober 2000
Other tests should be performed in order to confirm Hib infection during this period.
Za potrditev okužbe s Hib v tem obdobju je treba uporabiti druge teste.
Stability data indicate that the vaccine components are stable at temperatures up to 25°C for 72 hours.
Stabilnostni podatki kažejo, da so komponente cepiva stabilne 72 ur pri temperaturah do 25 °C.
However, sometimes it can be very serious and cause permanent damage or even death.
Včasih pa je lahko zelo resna in povzroči trajne poškodbe ali celo smrt.
The clinical relevance of these observations remains unknown.
Klinični pomen tega opažanja ni znan.
1adsorbed on Al(OH)3
1adsorbiran na Al(OH)3
They usually happen within 2 to 3 days after vaccination.
Navadno se pojavijo v dveh do treh dneh po cepljenju.
• a sudden drop in blood pressure and loss of consciousness.
• nenaden padec krvnega tlaka in izguba zavesti.
Tell your doctor if your child has had an allergic reaction to these ingredients.
Zdravniku povejte, če je vaš otrok imel alergično reakcijo na ti sestavini.
This will protect your child against these diseases.
To bo vašega otroka zaščitilo pred temi boleznimi.
• if your child has an undiagnosed or progressive disease of the brain or epilepsy which is not controlled.
• če ima vaš otrok nediagnosticirano ali napredujočo bolezen možganov ali epilepsijo, ki ni nadzorovana.
Freezing destroys the vaccine.
Zamrzovanje cepivo uniči.
Tell your doctor or pharmacist if your child is taking, has recently taken, might take any other medicines or has recently received any other vaccine.
Obvestite zdravnika ali farmacevta, če vaš otrok jemlje, je pred kratkim jemal ali pa bo morda začel jemati katero koli drugo zdravilo ali je pred kratkim prejel katero koli drugo cepivo.
Household contact study (prospective blinded)
Študija kontaktov v gospodinjstvu (prospektivna, slepa)
The arms or legs affected by the disease may be painfully twisted (deformed).
Noge in roke, ki jih bolezen prizadene, so lahko boleče ukrivljene (deformirane).
This includes the muscles needed for breathing and walking.
To lahko vključuje tudi mišice potrebne za dihanje in hojo.
• The vaccine cannot cause the diseases that it protects your child from.
• Cepivo ne more povzročiti bolezni, pred katerimi ščiti vašega otroka.
• Do not use this vaccine after the expiry date which is stated on the carton.
• Tega cepiva ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli.
If not, your child may not be fully protected against the diseases.
V nasprotnem primeru, je možno, da vaš otrok ni popolnoma zaščiten pred boleznimi.
Children at 7-8 years of age
Otroci stari 7-8 let
Evaluation of pharmacokinetic properties is not required for vaccines.
Vrednotenje farmakokinetičnih lastnosti za cepiva ni zahtevano.
These data are intended to guide healthcare professionals in case of temporary temperature excursion only.
Ti podatki so namenjeni kot navodilo zdravstvenim delavcem le v primeru krajših temperaturnih odstopov.
Frequencies per dose are defined as follows:
Pogostnost na odmerek je definirana kot sledi: Zelo pogosti:
4propagated in VERO cells
4namnožen v celicah VERO
A minor infection such as a cold should not be a problem, but talk to your doctor first.
Blažje okužbe, kot je na primer prehlad, ne bi smele biti težava, vendar se pred cepljenjem vseeno pogovorite s svojim zdravnikom.
• if your child has a severe infection with a high temperature (over 38°C).
• če ima hudo okužbo z zvišano telesno temperaturo (nad 38 °C).
• swelling of the eyes and face
• otekle oči in obraz,
As the benefit of the vaccination is high in these infants, vaccination should not be withheld or delayed.
Ker je korist cepljenja teh dojenčkov velika, cepljenja ne bi smeli odložiti ali ga izpustiti.
For pertussis there is no serological correlate of protection.
Za oslovski kašelj ni serološkega korelata zaščite.
• Safety in preterm infants:
• Varnost pri nedonošenčkih:
Hepatitis B immunological memory was confirmed in children 4 to 15 years of age.
Imunološki spomin za hepatitis B je bil potrjen pri otrocih od 4. do 15. leta starosti.
• Store in a refrigerator (2°C - 8°C).
• Shranjujte v hladilniku (2 °C - 8 °C).
Polio is often only a mild illness.
Otroška paraliza je pogosto le blaga bolezen.
not less than 40 International Units (IU)
ne manj kot 40 internacionalnih enot (i.e.)
• As with all vaccines, Infanrix hexa may not fully protect all children who are vaccinated.
• Tako kot velja za vsa cepiva, cepivo Infanrix Hexa morda ne bo popolnoma zaščitilo vseh cepljenih otrok.
These signs usually start very soon after the injection has been given.
Ti znaki se navadno pojavijo kmalu po prejetju odmerka.
The vaccine may contain traces of formaldehyde, neomycin and polymyxin which are used during the manufacturing process (see section 4.3).
Cepivo lahko vsebuje sledi formaldehida, neomicina in polimiksina, ki se uporabljajo med proizvodnim procesom (glejte poglavje 4.3).
BATCH NUMBER LOT:
ŠTEVILKA SERIJE Lot:
2 Adverse reactions from spontaneous reporting.
2 Neželeni učinki iz spontanih poročil.
These reactions were mostly moderate (less than or equal to 39°C) and transient (see sections 4.5 and 4.8).
Večinoma so bile te reakcije zmerne (39 °C ali manj) in prehodne (glejte poglavji 4.5 in 4.8).
The signs may include:
Znaki so lahko:
not less than 30 International Units (IU)
ne manj kot 30 internacionalnih enot (i.e.)
• You will be told by the doctor or nurse when your child should come back for their next injections.
• Zdravnik ali sestra vam bosta naročila, kdaj mora vaš otrok priti po naslednje odmerke.
≥ 40 IU
≥ 40 i.e.
The results of these clinical studies are summarised in the tables below.
Spodaj so v preglednicah povzeti rezultati kliničnih študij.
The immune responses were unaffected.
Imunski odzivi so bili neprizadeti.
If your child has an allergic reaction, see your doctor straight away.
Če ima vaš otrok alergijsko reakcijo, nemudoma obiščite svojega zdravnika.
• Tetanus: tetanus bacteria enter the body through cuts, scratches or wounds in the skin.
• Tetanus: bakterije tetanusa pridejo v telo skozi vreznine, praske ali rane na koži.
Children at 4-5 years of age
Otroci stari 4-5 let
• The vaccine should never be given into a blood vessel or into the skin.
• Cepiva se ne sme nikoli dati v žilo ali pod kožo.
0.32 milligrams Al3+
0,32 miligramov Al3+
SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE
POSEBNI VARNOSTNI UKREPI ZA ODSTRANJEVANJE NEUPORABNIH ZDRAVIL ALI IZ NJIH NASTALIH ODPADNIH SNOVI, KADAR SO POTREBNI
Talk to a doctor straight away if they happen after leaving the doctor's surgery.
Nemudoma se posvetujte z zdravnikom, če se pojavijo po odhodu iz ambulante.
• Diphtheria: a serious bacterial infection that mainly affects the airways and sometimes the skin.
• Davica: resna bakterijska okužba, ki v glavnem prizadene dihalne poti in občasno kožo.
Infanrix hexa is a vaccine used to protect your child against six diseases:
Infanrix hexa je cepivo, ki vašega otroka lahko zaščiti pred šestimi boleznimi:
• difficulty in breathing or swallowing
• težave pri dihanju ali požiranju,
Collapse or shock-like state (hypotonichyporesponsive episode)2
Redki kolaps ali šoku podobno stanje (hipotonična-hiporesponzivna epizoda)2
• times when they lose consciousness or have a lack of awareness
• obdobja, ko otrok izgubi zavest ali se ne zaveda,
Very common Crying abnormal, irritability, restlessness Common
Zelo pogosti neobičajen jok, razdražljivost,
Pharmaco-therapeutic group: Bacterial and viral vaccines combined, ATC code: J07CA09
Farmakoterapevtska skupina: Kombinacija bakterijskih in virusnih cepiv, oznaka ATC: J07CA09 Imunogenost
The reconstituted vaccine appears as a slightly more cloudy suspension than the liquid component alone.
Rekonstituirano cepivo je na videz bolj motna suspenzija kot sama tekoča komponenta.
At the end of this period Infanrix hexa should be used or discarded.
Ob koncu tega obdobja morate cepivo Infanrix hexa uporabiti ali zavreči.
The vaccine is reconstituted by adding the entire contents of the pre-filled syringe to the vial containing the powder.
Cepivo rekonstituiramo z dodajanjem celotne vsebine napolnjene injekcijske brizge viali, ki vsebuje prašek.
Very rare (these may happen with up to 1 in 10,000 doses of the vaccine): itching (dermatitis).
Zelo redki (pojavijo se lahko pri največ 1 od 10.000 odmerkov cepiva): srbenje (dermatitis).
This can lead to serious problems such as mental slowness (retardation), cerebral palsy, deafness, epilepsy or partial blindness.
To lahko vodi do resnih težav, kot so miselna počasnost (zaostalost), cerebralna paraliza, gluhost, epilepsija ali delna slepota.
Clinical data generated with paracetamol and ibuprofen suggest that the prophylactic use of paracetamol might reduce the fever rate, while prophylactic use of ibuprofen showed a limited effect in reducing fever rate.
Klinični podatki pridobljeni s paracetamolom in ibuprofenom kažejo, da profilaktično uporabljeni paracetamol lahko zniža zvišano telesno temperaturo, medtem ko profilaktična uporaba ibuprofena kaže omejen učinek na znižanje zvišane telesne temperature.
Antipyretic treatment should be initiated according to local treatment guidelines.
Antipiretično zdravljenje naj poteka skladno z lokalnimi smernicami.
Read all of this leaflet carefully before your child receives this vaccine because it contains important information for you.
Preden vaš otrok dobi to cepivo, natančno preberite navodilo, ker vsebuje za vas pomembne podatke!
Primary vaccination Booster vaccination
Primarno cepljenje Obnovitveno cepljenje
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
Za vse morebitne nadaljnje informacije o tem cepivu se lahko obrnete na predstavništvo imetnika dovoljenja za promet s cepivom:
≥ 30 IU
≥ 30 i.e.
Vaccination should be preceded by a review of the medical history (especially with regard to previous vaccination and possible occurrence of undesirable events) and a clinical examination.
Pred cepljenjem moramo preučiti anamnezo otroka (s poudarkom na predhodnih cepljenjih in morebitnih neželenih učinkih) in opraviti klinični pregled.
The immunogenicity of Infanrix hexa has been evaluated in clinical studies from 6 weeks of age.
Imunogenost cepiva Infanrix hexa so ovrednotili v kliničnih študijah od 6 tednov starosti.
The mixed appearance is a white, slightly milky liquid.
Mešanica je bela, rahlo mlečna tekočina.
This can help to lower some of the side effects (febrile reactions) of Infanrix hexa.
To lahko pomaga zmanjšati nekatere neželene učinke (vročinske reakcije) cepiva Infanrix hexa.
See also section 4 Possible side effects.
Glejte tudi poglavje 4 Možni neželeni učinki;
0.5 milligrams Al3+
0,5 miligramov Al3+
If either is observed, discard the vaccine.
Če opazite karkoli od tega, cepivo zavrzite.
The safety and efficacy of Infanrix hexa in children over 36 months of age have not been established.
Varnost in učinkovitost cepiva Infanrix hexa pri otrocih, starejših od 36 mesecev, ni bila dokazana.
Vaccinees with a history of febrile convulsions should be closely followed up as such adverse events may occur within 2 to 3 days post vaccination.
Cepljene osebe z anamnezo vročinskih krčev je treba natančno spremljati, kajti takšni neželeni dogodki se lahko pojavijo v 2 do 3 dneh po cepljenju.
• The Hib component is a white powder presented in a glass vial.
• Hib komponenta je bel prašek v stekleni viali.
Booster doses should be given in accordance with the official recommendations, but, as a minimum, a dose of Hib conjugate vaccine must be administered.
Obnovitvene odmerke je treba dajati skladno z uradnimi priporočili, toda dati je treba vsaj en odmerek konjugiranega cepiva proti Hib.
The presence of a minor infection is not a contraindication.
Blage okužbe niso kontraindikacija.
Poliovirus (inactivated) type 1, 2, 3
10 mikrogramov poliovirus (inaktivirani) tip 1, 2, 3
1adsorbed on aluminium hydroxide, hydrated (Al(OH)3)
1adsorbiran na hidratirani aluminijev hidroksid (Al(OH)3)
• Your child will have a total of two or three injections with at least 1 month between each injection.
• Vaš otrok bo prejel skupaj dva ali tri odmerke z vsaj enomesečnim presledkom med odmerkoma.
Efficacy in protecting against pertussis
Učinkovitost zaščite proti oslovskemu kašlju
There may be circumstances, such as a high incidence of pertussis, when the potential benefits outweigh possible risks.
V nekaterih okoliščinah, kot je visoka pojavnost oslovskega kašlja, lahko pričakovana korist cepljenja prevlada nad možnim tveganjem.
• if your baby was born very prematurely (at or before 28 weeks of gestation) longer gaps than normal between breaths may occur for 2-3 days after vaccination.
• če je bil vaš dojenček rojen veliko prezgodaj (pred ali v 28 tednu gestacijske starosti) se lahko 2-3 dni po cepljenju pojavijo daljši presledki med vdihi.
However, as the immune response to pertussis antigens following Infanrix hexa administration is equivalent to that of Infanrix (DTPa), the protective efficacy of the two vaccines is expected to be equivalent.
Vendar, ker je imunski odziv na antigen pertusisa po uporabi cepiva Infanrix hexa enak kot po uporabi cepiva Infanrix (DTPa), je pričakovati, da bo zaščitni učinek obeh cepiv enak.
The primary vaccination schedule consists of two or three doses (of 0.5 ml) which should be administered according to official recommendations (see the table below and section 5.1 for schedules evaluated in clinical trials).
Odmerjanje Osnovno shemo cepljenja sestavljajo dva ali trije odmerki (po 0,5 ml), ki ju/jih je treba dati v skladu z uradnimi priporočili (za sheme, ki so bile ovrednotene v kliničnih preskušanjih, glejte spodnjo preglednico in poglavje 5.1).
Shake well before use
Pred uporabo dobro pretresite
Protective immunity against the three poliovirus types and PRP was observed in at least 91.0% of children and against diphtheria and tetanus in at least 64.7% of children.
Zaščitno imunost proti trem vrstam poliovirusov in PRP so opažali pri vsaj 91,0 % otrok in proti davici in tetanusu pri vsaj 64,7 % otrok.
N=2009 (12 studies)
N = 2009 (12 študij)
These babies may require respiratory monitoring for 48-72h following the administration of the first two or three doses of Infanrix hexa.
Pri teh dojenčkih bo morda potrebno nadzorovati dihanje 48-72 ur po cepljenju s prvima dvema od treh odmerkov cepiva Infanrix hexa.
Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.
Podrobne informacije o cepivu so objavljene na spletni strani Evropske agencije za zdravila: http://www.ema.europa.eu.
Hypersensitivity to the active substances or to any of the excipients listed in section 6.1, or formaldehyde, neomycin and polymyxin.
Preobčutljivost na zdravilne učinkovine ali katero koli pomožno snov, navedeno v poglavju 6.1 ali formaldehid, neomicin in polimiksin.
It causes severe coughing that may lead to problems with breathing.
Povzroča hud kašelj, ki lahko povzroči težave z dihanjem.
The causal relationship to the vaccine has not been established.
Vzročna povezava s cepivom ni bila dokazana.
The immunogenicity of a booster dose at 18 to 24 months of age was evaluated in approximately 200 preterm infants.
Imunogenost obnovitvenega odmerka v starosti od 18 do 24 mesecev so ocenili pri približno 200 nedonošenčkih.
Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.
Tabelarični pregled neželenih učinkov V razvrstitvah pogostnosti so neželeni učinki navedeni po padajoči resnosti.
A. MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCES AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
A. IZDELOVALCI BIOLOŠKE ZDRAVILNE UČINKOVINE (UČINKOVIN) IN IZDELOVALEC, ODGOVOREN ZA SPROŠČANJE SERIJ
Over a six year period starting in 2006, where Infanrix hexa was the principal Hib-containing vaccine in use with vaccination coverage exceeding 95%, Hib invasive disease continued to be well controlled, with four confirmed Hib cases reported in Italian children aged less than 5 years through passive surveillance.
Med šestletnim obdobjem, ki se je začelo leta 2006, ko je bilo cepivo Infanrix hexa glavno uporabljano cepivo s Hib (z več kot 95 % pokritjem cepljenj), je ostala invazivna bolezen Hib dobro obvladana; s pasivnim spremljanjem so bili pri italijanskih otrocih, mlajših od 5 let, zabeleženi štirje potrjeni primeri Hib.
Due to an increased risk of fever, pain at the injection site, appetite lost and irritability when Infanrix hexa was co-administered with MenB vaccine and 7-valent pneumococcal conjugate vaccine, separate vaccinations can be considered when possible.
Zaradi povečanega tveganja za zvišano telesno temperaturo, bolečine na mestu injiciranja, izgubo apetita in razdražljivost pri sočasni uporabi cepiva Infanrix hexa s cepivom proti MenB in 7-valentnim pnevmokoknim konjugiranim cepivom, se lahko razmisli o ločenih cepljenjih, kadar je to možno.
• Haemophilus influenzae type b (Hib): can cause brain swelling (inflammation).
• Haemophilus influenzae tipa b (Hib): lahko povzroča oteklino možganov (vnetje).
Preterm infants born after at least 24 weeks of gestational age 3-dose
Nedonošenčki, rojeni po vsaj 24 tednih gestacijske starosti
The use of Infanrix hexa should be in accordance with official recommendations.
Uporaba cepiva Infanrix hexa mora biti v skladu z uradnimi priporočili.
If any of the above apply to your child (or you are not sure), talk to your doctor or pharmacist before your child is given Infanrix hexa.
Če karkoli od navedenega velja za vašega otroka (ali če niste prepričani), se posvetujte z zdravnikom ali s farmacevtom, preden bo vaš otrok cepljen s cepivom Infanrix hexa.
Germany 3,4,5 months 88.7% Based on data collected from secondary contacts in households where there was an index case with typical pertussis
88,7 % Na podlagi podatkov zbranih po drugem obisku v gospodinjstvih, v katerih so imeli primer značilnega oslovskega kašlja.
To attach the needle to the syringe, twist the needle clockwise into the syringe until you feel it lock (see picture).
Iglo namestite na brizgo tako, da iglo zasučete v smeri urnega kazalca na brizgo, dokler se ne zaskoči (glejte sliko).